Royal Bank of Canada »

Avita Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 4.5k 5.88
2025-06-30 $0 84 0.00
2025-03-31 $7.3k 871 8.37
2024-12-31 $10k 737 14.08
2024-09-30 $33k 2.8k 11.85
2024-06-30 $16k 2.6k 6.17
2024-03-31 $25k 1.5k 15.93
2023-12-31 $98k 7.0k 13.90
2023-09-30 $60k 4.0k 15.20
2023-06-30 $35k 1.7k 20.27
2022-12-31 $3.0k 400 7.50
2022-09-30 $2.0k 400 5.00
2021-06-30 $41k 2.0k 20.00
2021-03-31 $8.0k 400 20.00
2020-12-31 $7.0k 400 17.50
2020-09-30 $17k 468 35.71
2020-06-30 $13k 440 29.55